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 Association Between Pathogens Detected Using 
Quantitative Polymerase Chain Reaction With 
Airway Infl ammation in COPD at Stable State and 
Exacerbations 
 Bethan L.  Barker ,  BMBS ;  Koirobi  Haldar ,  MSc ;  Hemu  Patel ,  BSc ;  Ian D.  Pavord ,  MD ;  Michael R.  Barer ,  PhD ; 
 Christopher E.  Brightling ,  PhD ,  FCCP ; and  Mona  Bafadhel ,  PhD 
 BACKGROUND:  Relationships between airway infl ammation and respiratory potentially patho-
genic microorganisms (PPMs) quantifi ed using quantitative polymerase chain reaction (qPCR) 
in subjects with COPD are unclear. Our aim was to evaluate mediators of airway infl ammation and 
their association with PPMs in subjects with COPD at stable state and during exacerbations. 
 METHODS:  Sputum from 120 stable subjects with COPD was analyzed for bacteriology (colony-
forming units; total 16S; and qPCR targeting  Haemophilus infl uenzae , Moraxella catarrhalis , and 
 Streptococcus pneumoniae ), diff erential cell counts, and infl ammatory mediators using the 
Meso-Scale Discovery Platform. Subjects were classifi ed as colonized if any PPM was identifi ed 
above the threshold of detection by qPCR. Symptoms were quantifi ed using the visual analog scale. 
 RESULTS:  At stable state, 60% of subjects were qPCR positive for  H influenzae , 48% for 
 M catarrhalis , and 28% for  S pneumoniae . Elevated sputum concentrations of IL-1 b , IL-10, and 
tumor necrosis factor (TNF)- a were detected in samples qPCR positive for either  H infl uenzae 
or  M catarrhalis . Bacterial loads of  H infl uenzae positively correlated with IL-1 b , IL-8, IL-10, 
TNF- a , and symptoms; and  M catarrhalis correlated with IL-10 and TNF- a .  H infl uenzae 
qPCR bacterial load was an independent predictor of sputum TNF- a and IL-1 b . In 55 subjects 
with paired exacerbation data, qPCR bacterial load fold change at exacerbation in  M catarrhalis 
but not  H infl uenzae correlated to changes in sputum TNF- a and IL-1 b concentrations. 
 CONCLUSIONS:  At stable state,  H infl uenzae is associated with increased airway infl ammation 
in COPD. Th e relationship between bacterial load changes of specifi c pathogens and airway 
infl ammation at exacerbation and recovery warrants further investigation. 
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 COPD is characterized by irreversible airfl ow obstruction 
and airway infl ammation. Th e disease course is punctu-
ated by exacerbation episodes, 1 which are oft en associ-
ated with increased airway infl ammation, 2 viruses, and 
bacteria. 3 Bacteria are isolated from sputum cultures in 
30% to 40% of subjects with stable COPD 3-7 and found 
in approximately 50% of subjects during exacerbation 
episodes. 7,8 Colonization with bacteria is associated with 
worsened health status, 6 reduced lung function, 9 and an 
increase in the frequency and severity of exacerbations. 10 
Additionally, patients with positive sputum cultures 
have an associated increased infl ammatory response 
detected by elevated levels of sputum neutrophils, 11 
IL-8, 12-14 IL-6, 13 tumor necrosis factor (TNF)- a , 13 myelo-
peroxidase, 14 and leukotriene B4. 6 Both culture-based 
and culture-independent molecular techniques have 
shown that  Haemophilus infl uenzae is the commonest 
sputum pathogen in stable COPD. 15,16 Although studies 
using culture-based techniques have suggested that air-
way infl ammation is higher in those colonized with 
 H infl uenzae , 15-17 relationships between pathogens quanti-
fi ed using molecular techniques and airway infl ammation 
are unclear. In this study using quantitative polymerase 
chain reaction (qPCR) to measure pathogen-specifi c 
bacterial loads, we hypothesized that detection of the 
respiratory potentially pathogenic microorganisms (PPMs) 
( H influenzae, Moraxella catarrhalis ,  Streptococcus 
pneumoniae , and  Staphylococcus aureus ) in subjects with 
COPD is associated with increased airway infl ammation 
at stable state and during exacerbations. 
 Materials and Methods 
 Subjects 
 Sputum samples from subjects aged   40 years and with postbroncho-
dilator FEV 1/ FVC  , 0.7 enrolled within an observational COPD exacerba-
tion cohort study were analyzed. Th e study design and inclusion and 
exclusion criteria have been described previously. 3 Subjects with COPD 
on prophylactic antibiotic therapy were excluded. Th e study was con-
ducted in accordance with the amended Declaration of Helsinki and was 
approved by the Leicestershire, Northamptonshire, and Rutland ethics 
committee (07/H0406/157). All patients gave informed written consent. 
 Measurements 
 Baseline demographic information, smoking history, medication history, 
and patient-reported history of exacerbations were collected. Subjects 
were reviewed when clinically stable and during exacerbation episodes; 
stable visits took place a minimum of 8 weeks aft er exacerbation episodes. 
Exacerbations were defi ned according to the criteria of Anthonisen et al 18 
and health-care use 19 and treated according to guidelines. 20 Exacerbation 
testing and sampling was only performed in subjects who were treat-
ment naive for the episode. At all visits, spirometry and symptom 
assessment using the St. George’s Respiratory Questionnaire (SGRQ), 21 
the Chronic Respiratory Questionnaire, 22 and the visual analog scale 
(VAS) 23 were undertaken. Spontaneous or induced sputum sampling 
was collected for analysis of microbiology, diff erential cell counts, and 
cytokine analysis, as described later. No diff erences in infl ammatory 
counts between spontaneous or induced sputum samples were identi-
fi ed in this study, in keeping with other studies, 24,25 and  . 95% of sub-
jects provided spontaneous sputum samples. CT imaging, to investigate 
bronchiectasis, was not performed as part of the study protocol; how-
ever, CT scans performed as part of a routine clinical investigation were 
interrogated in subjects who entered the study. 
 Sputum Assessments 
 Bacterial load was measured by colony-forming units (CFU) as per 
standard methods 26 and quantitative polymerase chain reaction (qPCR) 
as previously described. 3 Th e CFU is a semiquantitative analysis of total 
live bacterial counts, and a quantitative analysis of both live and dead 
bacteria was quantifi ed using qPCR, estimating both the total bacterial 
load based on the abundance of 16S ribosomal subunit encoding genes 
(total 16S). Pathogen-specifi c bacterial 16S abundance using qPCR was 
measured for  H infl uenzae , M catarrhalis ,  S pneumoniae , and  S aureus 
 ( Pseudomonas aeruginosa was not measured by qPCR in this study). 
Quantifi cation of the total bacterial load of  H infl uenzae and  S aureus 
was performed using the SYBR Green assay (Life Technologies ). Th e 
TaqMan assay (Life Technologies) was used to quantify  M catarrhalis 
and  S pneumoniae (target genes and primers listed in  e-Table 1 ).  S aureus 
was infrequently detected, and therefore any results relating to this 
pathogen were not analyzed further. The threshold of detection for 
pathogen-specifi c bacterial 16S qPCR analysis and CFU counts was taken 
as 1  3 10 4 genome copies/mL and 1  3 10 5 colonies/mL of sputum, 
respectively, refl ecting previous cutoff  thresholds used in this fi eld. 27,28 
Subjects were categorized as pathogen-specifi c bacterial 16S qPCR pos-
itive detection if any qPCR PPM (defi ned in this study as identifi cation 
of  H infl uenzae , M catarrhalis ,  S pneumoniae , and  S aureus ) was identi-
fi ed above the threshold. Subjects were classifi ed as codetection if more 
than one pathogen-specifi c bacterial 16S qPCR PPM was identifi ed above 
the threshold of identifi cation. Sputum was simultaneously processed to 
obtain cytospins for diff erential cell counts and cell-free supernatants as pre-
viously described. 29 Th e sputum infl ammatory mediators IL-1 b , IL-5, IL-6, 
IL-8, IL-10, TNF- a , TNFRI, CXCL10, CCL2, CCL3, CCL4, CCL5, CCL13, 
and CCL17 were measured using the Meso Scale Discovery Platform 
(Meso Scale Diagnostics, LLC) from sputum supernatants. 25 All media-
tors, except IL-10, measured using the MSD were detectable and above 
the limit of detection in  . 75% of samples (IL-10 was above the limit of 
detection in  . 50% of samples; limits of detection presented in  e-Table 2 ). 
 Statistical Analysis 
 Statistical analysis was performed using SPSS version 20 (IBM) and 
PRISM version 6 (GraphPad Software, Inc). Parametric data were 
expressed as mean (SEM), nonparametric data as median (interquartile 
range), and log-normally distributed data as geometric mean (95% CI). 
Unpaired parametric and nonparametric groups were compared using 
the Student  t test and Mann-Whitney test, respectively. The paired 
 t test was used to compare matched stable and exacerbation measures 
of airway bacterial load and sputum infl ammatory mediators. For com-
parison of three or more groups, the one-way analysis of variance was 
used, with repeated analysis of variance for paired data. Th e  x 2 test was 
used to compare proportions between groups. Pearson correlation 
coefficient was used to assess correlations between qPCR-measured 
airway bacterial load and sputum infl ammatory mediators. Multivari-
ate stepwise regression analysis was performed to model the eff ects of 
bacterial load on proinflammatory cytokine expression, namely spu-
tum TNF- a and IL-1 b . Variables that demonstrated signifi cance at the 
 P  , .10 level using univariate analysis were entered into the model: 
 H infl uenzae and  M catarrhalis bacterial load, sputum total cell count, 
percentage sputum neutrophils, and CFU. Exacerbation frequency and 
% FEV 1 predicted were also entered into the model for clinical relevance. 
Th e regression model did not show violation of multicollinearity or 
homoscedasticity, and the residuals observed normality. No corrections 
for multiple mediator measurements were performed. A  P value  , .05 
was taken as the threshold of signifi cance for all statistical testing. 
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 Results 
 Stable sputum samples with full complement of infl am-
matory mediators were obtained from 120 subjects 
(83 men). Th e clinical characteristics are presented in 
 Table 1 . A CT scan was available in 93 subjects (77.5%), 
and bronchiectasis was detected in 18 (19.4%). Th ere 
were no significant differences in the clinical 
parameters between the subjects with COPD with or 
without detectable pathogen-specific bacterial 
16S qPCR PPM. Subjects with PPMs on qPCR had 
more severe airfl ow obstruction and increased CFU 
but not total 16S ( Table 1 ). Th ere was no correlation 
between total 16S qPCR and inhaled corticosteroid 
dose, smoking pack-years, or exacerbation frequency. 
Th e distribution of qPCR pathogen codetection is pre-
sented in  Figure 1 . 
 qPCR and Inﬂ ammation During Stable State 
 Subjects with pathogen-specifi c bacterial 16S qPCR 
PPM had higher levels of IL-1 b and TNF- a and lower 
 TABLE 1  ]  Clinical Characteristics of Subjects According to Whether There Was a Pathogen-Speci¿ c Bacterial 
16S qPCR PPM Detected Above the Limit of Detection a  
Characteristic qPCR PPM Negative (n  5 28) qPCR PPM Positive (n  5 92)  P Value
Age, mean (range), y 70 (48-87) 69 (43-88) .37
Ex-smokers, No. (%) 20 (71) 63 (68) .82
Proportion on ICS, No. (%) 24 (86) 81 (88) .75
ICS dose, median (IQR), mg (BDP equivalent) 1,300 (800-2,000) 2,000 (800-2,000) .55
Pack-y history 45 (10-120) 49 (10-153) .56
FEV 1 , L 1.47 (0.09) 1.32 (0.06) .20
FEV 1 /FVC % 61 (4) 53 (2) .05
FEV 1 % 59 (4) 51 (2) .06
Exacerbations in previous y 3.8 (0.5) 3.5 (0.3) .59
SGRQ symptoms, units 62.2 (94.1) 57.2 (2.4) .31
SGRQ activities, units 70.2 (4.0) 65.7 (2.3) .35
SGRQ impacts, units 34.7 (3.6) 37.0 (2.0) .58
SGRQ total, units 49.6 (3.3) 48.7 (1.9) .82
CRQ emotion, units 4.7 (0.2) 4.7 (0.2) .97
CRQ fatigue, units 3.6 (0.2) 3.6 (0.1) .92
CRQ dyspnea, units 3.4 (0.2) 3.3 (0.1) .69
CRQ mastery, units 4.9 (0.3) 4.9 (0.2) .82
CRQ total, units 4.2 (0.2) 4.1 (0.1) .10
VAS cough, mm 35 (6) 39 (3) .45
VAS dyspnea, mm 50 (5) 47 (3) .64
VAS sputum production, mm 29 (5) 38 (3) .13
VAS sputum purulence, mm 33 (5) 29 (3) .55
Log CFU/mL, mean (95% CI) 6.6 (5.4-7.8) 7.5 (5.9-9.1)  , .01
Log 16S genome copies/mL, mean (95% CI) 8.2 (6.8-9.4) 8.4 (6.5-9.8) .37
Sputum total cell count,  3 10 6 /g 2.5 (1.8-3.7) 3.6 (2.5-5.1) .27
Sputum neutrophils, mean (range), % 64 (4) 72 (2) .09
Sputum neutrophil count,  3 10 6 /g 
(geometric mean, 95% CI)
1.6 (0.9-2.8) 2.4 (1.7-3.4) .22
Sputum eosinophils, % (geometric mean, 
95% CI)
1.6 (1.1-2.2) 1.3 (0.9-1.9) .61
Proportion with bronchiectasis, No. (%) b 4 of 19 (21) 14 of 74 (18) .74
 Data expressed as mean (SEM) unless otherwise stated. BDP  5 beclomethasone dipropionate; CFU  5 colony-forming units; CRQ  5 Chronic Respiratory 
Questionnaire; ICS  5 inhaled corticosteroid; PPM  5 potentially pathogenic microorganism; qPCR  5 quantitative polymerase chain reaction; SGRQ  5 
St. George’s Respiratory Questionnaire; VAS  5 visual analog scale. 
 a . 1  3 10 4  genome copies/mL. 
 b CT scans available in 93 out of 120 subjects. 
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levels of CCL13 ( Table 2 ,  e -Table 3 ); this was associated 
with a trend to a dose-response increase in infl amma-
tion with increasing numbers of qPCR PPMs ( Table 3 ). 
Th ere was no correlation of total bacterial 16S qPCR 
with infl ammation. Pathogen-specifi c 16S qPCR bacterial 
load in subjects positive for  H infl uenzae strongly corre-
lated with levels of IL-1 b , IL-8, IL-10, and TNF- a ( r  5 0.64, 
 P  , .01;  r  5 0.51,  P  , .01;  r  5 0.59,  P  , .01; and  r  5 0.71, 
 P  , .01, respectively). Pathogen-specifi c 16S qPCR bac-
terial load of  M catarrhalis moderately correlated with 
IL-10 and TNF- a levels ( r  5 0.31,  P  5 .02; and  r  5 0.39, 
 P  , .01) ( Fig 2 ). Multivariate regression analysis identi-
fi ed qPCR  H infl uenzae bacterial load and CFU as inde-
pendent predictors of sputum TNF- a and IL-1 b 
( H infl uenzae ,  b  5 0.38 and 0.32 for TNF- a and IL-1 b , 
respectively; and CFU,  b  5 0.36 and 0.31, respectively) 
( e-Table 4 ). In subjects with either  H infl uenzae  or 
M catarrhalis as a single pathogen (n  5 21 and n  5 13, 
respectively), only  H infl uenzae 16S qPCR bacterial load 
correlated with IL-1 b , IL-10, and TNF- a ( Fig 3 ); and 
only  H infl uenzae qPCR bacterial load correlated with 
VAS symptoms of cough and sputum purulence and 
the symptom domain of the SGRQ ( e-Fig 1 ). 
 qPCR and Inﬂ ammation During an Exacerbation 
 Paired stable and exacerbation sputum was available in 
55 subjects (men, n  5 43; mean FEV 1 % predicted, 51%) 
with an average time of sampling between stable and 
exacerbation of 49 days. All subjects were treated with 
oral antibiotic and corticosteroid therapy at the onset 
of an exacerbation. During an exacerbation, pathogen-
specifi c 16S qPCR for  H infl uenzae , M catarrhalis , and 
 S pneumoniae were detected in 32 (58%), 26 (47%), 
and 20 (36%) subjects, respectively; the majority 
of these subjects had the same PPM qPCR at stable 
state (66%  H influenzae , 69%  M catarrhalis , and 
55%  S pneumoniae ). In subjects who were pathogen-
specifi c bacterial 16S qPCR PPM positive for  H infl uenzae 
and  M catarrhalis at exacerbation, the change in cytokine 
concentration between stable state and exacerbation was 
most marked in those who were also positive rather than 
negative in stable state ( e -Table 5 ). The change in 
pathogen-specifi c 16S  H infl uenzae qPCR bacterial load 
between stable and exacerbation visits did not correlate 
with change in cytokines or change in symptoms. Th e 
change in pathogen-specifi c 16S  M catarrhalis qPCR bac-
terial load between stable and exacerbation was positively 
 Figure 1 – Proportional Venn dia-
gram depicting the distribution of 
qPCR codetection at baseline for all 
subjects. H. infl uenzae  5  Haemophilus 
infl uenzae ; HI  5  Haemophilus 
infl uenzae ; M. catarrhalis  5  Moraxella 
catarrhalis ; MC   5  Moraxella 
catarrhalis ; qPCR  5 quantitative 
polymerase chain reaction; 
S. pneumoniae  5  Streptococcus 
pneumoniae ; SP  5  Streptococcus 
pneumoniae . 
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 TABLE 2  ]  Cytokine Levels According to Whether There Was a Pathogen-Speci¿ c Bacterial 16S qPCR PPM 
Detected 
Cytokine, pg/mL qPCR PPM Negative (n  5 28) qPCR PPM Positive (n  5 92)  P Value
IL-1 b 45 (30-68) 142 (93-217)  , .01
IL-5 1.3 (0.7-2.3) 1.0 (0.7-1.4) .58
IL-6 292 (162-527) 331 (236-464) .73
IL-8 3,104 (1,940-4,965) 3,707 (2,916-4,712) .49
IL-10 0.3 (0.2-0.5) 1.8 (1.2-2.7)  , .01
TNF- a 2.2 (1.1-4.2) 7.2 (4.6-11.5)  , .01
TNFRI 834 (573-1,213) 1,222 (1,003-1,489) .07
CCL2 605 (426-860) 548 (441-682) .66
CCL3 70 (47-105) 74 (58-94) .83
CCL4 957 (607-1,510) 989 (737-1,327) .91
CCL5 3.2 (1.8-5.7) 4.4 (3.5-5.5) .23
CCL13 47 (31-71) 26 (20-34) .03
CCL17 33 (20-55) 23 (17-30) .21
CXCL10 404 (260-627) 252 (188-337) .12
 Data presented as geometric mean (95% CI). TNF  5 tumor necrosis factor. See  Table 1 legend for expansion of other abbreviations . 
correlated with a change in IL-1 b and TNF- a ( r  5 0.37, 
 P  , .01;  r  5 0.31,  P  5 .02, respectively) ( e-Fig 2 ) but was 
not related to changes in symptoms or health status. 
 Discussion 
 In this study we have shown that the majority of sub-
jects with COPD at stable state had pathogenic bacteria 
detected by qPCR. Th e detection of bacteria using qPCR 
was associated with increased sputum IL-1 b , IL-10, and 
TNF- a and decreased CCL13. In stable state, the stron-
gest relationship between bacterial load, infl ammation, 
and symptoms was observed with pathogen-specifi c 
16S  H infl uenzae qPCR, whether in codetection with 
other bacteria or as a lone pathogen. Furthermore, we 
determined that  H infl uenzae qPCR bacterial load was 
the only pathogen that was an independent predictor 
of sputum TNF- a and IL-1 b levels, both infl ammatory 
chemokines. In our study, we determined that both total 
16S and CFU were elevated in subjects with detectable 
pathogen-specifi c 16S but only CFU bacterial load, which 
suggests live bacteria growth, was independently also 
associated with increased infl ammation. At exacerba-
tion, we have also shown that change of  M catarrhalis , 
but not  H infl uenzae , bacterial load at exacerbation com-
pared with stable state correlated with change in sputum 
TNF- a and IL-1 b concentrations. Together, these 
fi ndings suggest there is a complex dynamic relation-
ship in COPD between bacterial load of specifi c patho-
gens, airway infl ammation, and clinical expression of 
disease. 
 Our work represents the largest study to date using 
qPCR techniques to describe codetection in COPD. 3,27,30 
Prevalence of codetection was not described by 
Garcha et al, 27 and, similar to our fi ndings, Curran et al 30 
described, in a small study of 30 subjects with COPD, 
the presence of codetection using qPCR in 80% of sub-
jects. Consistent with studies using culture-based 15,16 
and culture-independent 27 techniques, we report here 
that  H infl uenzae was the most commonly identifi ed 
organism by qPCR. Th e presence of any detectable PPM 
was associated with increased airway infl ammation and 
increased proinfl ammatory cytokines. Our data suggest 
that sputum TNF- a and IL-1 b are more closely related 
to bacterial load, particularly with  H infl uenzae , which 
was found to be an independent predictor of sputum 
TNF- a and IL-1 b levels and associated with increased 
symptoms. Although this association does not confi rm 
causality, there are several biologically plausible reasons 
that  H infl uenzae may be of most signifi cance. First, 
up-regulation of the MRLP3 infl ammasome occurs 
during nontypeable  H infl uenzae -induced infl ammation 
leading to secretion of IL-1 b 31 ; second, the outer mem-
brane protein P6 of nontypeable  H infl uenzae has been 
found to induce the stimulation of TNF- a and IL-10 
from human alveolar macrophages. 32,33 Furthermore, 
alveolar macrophages have the greatest reduction of 
complement-independent phagocytosis of nontypeable 
 H infl uenzae . 34 However, it must be noted that qPCR 
techniques measure both live and dead bacteria. Our 
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observation that CFU bacterial load and  H infl uenzae 16S 
pathogen-specifi c bacterial load were closely associated 
with sputum levels of TNF- a and IL-1 b may suggest 
that live  H infl uenzae is driving this infl ammation, but 
further studies to investigate this are warranted. 
 We also observed that CCL13, which is increased in 
eosinophilic airway disease, 35 was reduced in subjects with 
pathogen-specifi c 16S qPCR PPM detection, irrespective 
of pathogen. Although we could not show that there is 
increased neutrophilic infl ammation, with elevated IL8 or 
sputum neutrophils percent as demonstrated in previous 
studies, 11,36 there was a trend to increase in total cell counts 
and absolute sputum neutrophil counts as codetection of 
pathogen increased and a positive correlation of IL-8 
with bacterial load, further suggesting a diff erential air-
way pattern of infl ammation with qPCR PPM detection. 
IL-10, an antiinfl ammatory cytokine, was also found to be 
increased in subjects with pathogen-specifi c 16S qPCR 
PPM and correlated with  H infl uenzae bacterial load. Spe-
cifi cally, the outer membrane protein P6 of  H infl uenzae 
has been shown to be a potent macrophage inducer of 
infl ammation, 33 and chronic upregulation and stimula-
tion of macrophages may contribute to further to the 
pathogenesis of COPD infections. 37 
 In contrast to earlier reports, we were unable to detect 
signifi cant diff erences in exacerbation frequency, 
smoking, or inhaled corticosteroid dose between colo-
nized and noncolonized subjects. 27 However, we have 
demonstrated a positive association between symptoms 
and  H infl uenzae bacterial load. We report here that the 
relationship between bacterial load and symptoms is 
pathogen specifi c and again supports a central role for 
sputum  H infl uenzae bacterial load in chronic persistent 
disease. Whether therapy specifi cally targeted at reducing 
 H infl uenzae bacterial load during stable state to reduce 
infl ammatory activity in COPD is clinically benefi cial is 
currently unknown and warrants further study. 
 Previous studies have demonstrated that airway infl am-
mation increases during exacerbation episodes 3,12 and 
that the presence of PPM during exacerbations is associ-
ated with increased IL-8, IL-1 b , and TNF- a . 3,38,39 However, 
limited data examining relationships between specifi c 
pathogens and infl ammation during exacerbations exist. 
 TABLE 3  ]  Parameters of Sputum InÀ ammation According to Number of qPCR Pathogens Found at Baseline 
Parameter 0 qPCR Positive (n  5 28) 1 qPCR Positive (n  5 38)   2 qPCR Positive (n  5 54)  P Value
IL-1 b , pg/mL 45 (30-68) 111 (55-222) 169 (100-287) .01
IL-5, pg/mL 1.3 (0.7-2.3) 1.4 (0.9-2.0) 0.8 (0.5-1.4) .34
IL-6, pg/mL 292 (162-527) 473 (278-806) 258 (168-395) .20
IL-8, pg/mL 3,104 (1,940-4,965) 3,578 (2,357-5,434) 3,799 (2,851-5,064) .77
IL-10, pg/mL 0.3 (0.2-0.5) 1.9 (0.9-3.6) 1.8 (1.0-3.0)  , .01
TNF- a , pg/mL 2.2 (1.1-4.2) 5.4 (2.6-1.4) 8.8 (4.9-15.9) .02
TNFRI, pg/mL 843 (573-1,213) 1,211 (903-1,623) 1,229 (940-1,608) .20
CCL2, pg/mL 605 (426-860) 697 (482-1,007) 463 (358-600) .16
CCL3, pg/mL 70 (47-105) 85 (56-128) 67 (50-90) .64
CCL4, pg/mL 957 (607-1,509) 1,212 (793-1,851) 858 (574-1,281) .50
CCL5, pg/mL 3.2 (1.8-5.7) 4.7 (3.3-6.9) 4.2 (3.1-5.5) .43
CCL13, pg/mL 47 (31-71) 37 (27-51) 21 (14-30)  , .01
CCL17, pg/mL 33 (20-55) 31 (22-44) 18 (12-27) .07
CXCL10, pg/mL 404 (260-627) 334 (211-529) 207 (142-300) .07
Log CFU/mL, mean (95% CI) 6.6 (5.4-7.8) 7.3 (5.8-9.1 ) 7.5 (6.0-9.1)  , .01
Log 16S genome copies/mL, 
mean (95% CI)
8.2 (6.8-9.4) 8.2 (6.1-9.7) 8.5 (6.8-10.0) .11
Total cell count,  3 10 6 /g 2.5 (1.9-3.7) 3.0 (1.9-4.6) 4.1 (2.8-5.9) .31
Sputum neutrophils, 
mean (SEM), %
64 (4) 68 (4) 75 (3) .06
Sputum neutrophil 
count,  3 10 6 /g
1.6 (0.9-2.8) 1.9 (1.1-3.2) 2.9 (1.9-4.6) .20
Sputum eosinophils, % 1.6 (1.1-2.2) 1.6 (1.0-2.7) 1.1 (0.8-1.7) .41
 Data presented as geometric mean (95% CI) unless otherwise stated. See Table 1 and 2 legends for expansion of abbreviations. 
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 Figure 2 – A-F, Correlations between the sputum mediator concentrations (A) TNF a , (B) IL1 b , (C) IL8, (D) IL6, (E) IL10, and (F) CXCL10 and spu-
tum bacterial load of HI, MC, and SP. TNF  5 tumor necrosis factor. See  Figure 1 legend for expansion of other abbreviations. 
To our knowledge, this is the fi rst study to explore rela-
tionships between dynamic changes in pathogen-specifi c 
bacterial load and infl ammation at exacerbation. We 
found that change in infl ammatory mediators at exacer-
bation compared with stable state was greatest in subjects 
who were pathogen-specifi c bacterial 16S qPCR PPM 
positive for either  H infl uenzae or  M catarrhalis at stable 
state. Th is suggests that there is activation of infl amma-
tion in stable state and colonized subjects with COPD, 
which is then further exaggerated at exacerbation. At 
stable state,  H infl uenzae is closely related to airway 
inflammation and clinical outcomes; however, at 
exacerbation, changes in infl ammation are more closely 
related to changes (including increases and decreases) 
of pathogen-specifi c bacterial 16S qPCR  M catarrhalis 
bacterial loads. Th e role of this pathogen during exacer-
bations of COPD needs to be investigated further. 
 One potential limitation of this study was the use of 
spontaneous sputum to determine sputum infl amma-
tory mediators and pathogen detection. Sputum collec-
tion predominately arises from the larger airways; thus, 
our results cannot infer causality of detectable patho-
gens and increased infl ammation in the pathogenicity 
of COPD, a predominately small airways disease. How-
ever, only samples with a squamous cell contamina-
tion  , 5% were used, and infl ammatory mediators 
measured from induced and spontaneous samples have 
not been shown to be diff erent, 24 suggesting that the 
strong associations found between airway bacterial 
load and sputum infl ammatory mediator concentrations 
were not clinically signifi cant. During this study, we also 
selected cutoff s to determine the presence or absence of 
pathogen-specifi c 16S qPCR. Although this is an arbi-
trary cutoff , we acknowledge that this is in part because 
of a paucity of the literature, which may be missing or 
overdetecting pathogens, but we have used cutoff s 
derived from previous studies using qPCR platforms in 
patients with COPD. 27 We have defi ned the presence of 
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 Figure 3 – A-F, Correlations between the sputum mediator concentrations (A) TNF a , (B) IL1 b , (C) IL8, (D) IL6, (E) IL10, and (F) CXCL10 and spu-
tum bacterial load of HI and MC in the subgroup of subjects qPCR positive for a single pathogen only. See  Figure 1 and 2 legends for expansion of 
abbreviations. 
pathogen in sputum samples as detection and not colo-
nization in this study, as the stable measurements were 
performed only at one time point, and we cannot com-
ment on whether there is transient detection of patho-
gens using qPCR methods or persistence; it is clear that 
more work is needed to interrogate the stability and 
repeatability of pathogen-specifi c 16S qPCR in patients 
with COPD. A further limitation is that the presence of 
 P aeruginosa was not assessed using qPCR techniques 
in this study. Although previous culture studies have 
suggested airway infl ammation is higher in subjects in 
whom  P aeruginosa is detected, 14 its prevalence in other 
COPD cohorts has been low. 27 Moreover, within our 
cohort, only fi ve of 120 patients had grown  P aeruginosa 
on sputum cultures within the preceding 12 months, 
and hence its exclusion from our analysis is unlikely to 
have signifi cantly infl uenced our results. In our study 
we chose primers targeting specifi c pathogens in the 
respiratory tract, as they have previously been deemed 
clinically significant. However, these techniques 
cannot refl ect the total microbiologic diversity within 
the airway, and newer techniques that can characterize 
the entire microbiome need to be studied further. 40-42 
Finally, measuring sputum mediators can be fraught 
with diffi  culty, with variability in detection 43-45 ; however, 
we have only analyzed mediators that were known to 
be detectable using a sputum-processing method that 
we have previously validated in patients with airway 
disease. 25 
 Conclusions 
 In summary, using qPCR we found that in patients with 
COPD, sputum pathogens are frequently detected. 
 H infl uenzae was associated with increased airway infl am-
mation and symptoms in a dose-response relationship 
with sputum TNF- a and IL-1 b .  M catarrhalis was more 
closely related to dynamic changes observed at exacer-
bation. Th e mechanisms by which  H infl uenzae and 
 M catarrhalis are related to airway infl ammation in 
COPD warrant further investigation. 
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